Pimecrolimus Completed Phase 3 Trials for Perioral Dermatitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00232115Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis